Skip to main content

Advertisement

Log in

Hepatic nodules with arterial phase hyperenhancement and washout on enhanced computed tomography/magnetic resonance imaging: how to avoid pitfalls

  • Special Section: Chronic Liver Disease
  • Published:
Abdominal Radiology Aims and scope Submit manuscript

Abstract

This essay aimed to illustrate the various hepatic nodules that may exhibit arterial phase hyperenhancement and washout on computed tomography/magnetic resonance imaging (CT/MRI). Hepatic nodules with arterial phase hyperenhancement and washout on CT/MRI include hepatocellular carcinoma, focal nodular hyperplasia-like nodules, serum amyloid A-positive hepatocellular neoplasms, intrahepatic cholangiocarcinoma, intrahepatic bile duct adenoma, hepatoblastoma, hepatocellular adenoma, hepatic epithelioid angiomyolipoma, and metastasis including neuroendocrine and gastrointestinal stromal tumors. Understanding the imaging findings is important to ensure correct diagnosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10
Fig. 11
Fig. 12

Similar content being viewed by others

References

  1. Marrero JA, Kulik LM, Sirlin CB, Zhu AX, Finn RS, Abecassis MM, Roberts LR, Heimbach JK (2018) Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology 68 (2):723-750. https://doi.org/10.1002/hep.29913

    Article  PubMed  Google Scholar 

  2. Kim MJ, Lee S, An C (2019) Problematic lesions in cirrhotic liver mimicking hepatocellular carcinoma. Eur Radiol 29 (9):5101-5110. https://doi.org/10.1007/s00330-019-06030-0

    Article  PubMed  Google Scholar 

  3. Victoria C, Claude BS (2018) The LI-RADS v2018 Manual. ACR. https://www.acr.org/-/media/ACR/Files/Clinical-Resources/LIRADS/LI-RADS-2018-Manual-5Dec18.pdf

  4. [4] Forner A, Reig M, Bruix J (2018) Hepatocellular carcinoma. The Lancet 391 (10127):1301-1314. https://doi.org/10.1016/s0140-6736(18)30010-2

    Article  Google Scholar 

  5. Kitao A, Zen Y, Matsui O, Gabata T, Nakanuma Y (2009) Hepatocarcinogenesis: multistep changes of drainage vessels at CT during arterial portography and hepatic arteriography--radiologic-pathologic correlation. Radiology 252 (2):605-614. https://doi.org/10.1148/radiol.2522081414

    Article  PubMed  Google Scholar 

  6. European Association for the Study of the Liver. Electronic address eee, European Association for the Study of the L (2018) EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. Journal of hepatology 69 (1):182-236. https://doi.org/10.1016/j.jhep.2018.03.019

    Article  Google Scholar 

  7. Gupta S, Bent S, Kohlwes J (2003) Test characteristics of alpha-fetoprotein for detecting hepatocellular carcinoma in patients with hepatitis C. A systematic review and critical analysis. Ann Intern Med 139 (1):46–50. https://doi.org/10.7326/0003-4819-139-1-200307010-00012

  8. Li XW, Cai HS, Yang YH, Li C, Dong Z, Feng S-T, Luo YJ (2017) Application of enhanced MR multi-phase dynamic scanning with 3D-VIBE sequence in hepatocellular carcinoma. Journal of Sun Yat-sen University (Medical Sciences) 38 (6):900-908. https://doi.org/10.13471/j.cnki.j.sun.yat-sen.univ(med.sci).2017.0143

    Article  Google Scholar 

  9. Iannaccone R, Piacentini F, Murakami T, Paradis V, Belghiti J, Hori M, Kim T, Durand F, Wakasa K, Monden M, Nakamura H, Passariello R, Vilgrain V (2007) Hepatocellular carcinoma in patients with nonalcoholic fatty liver disease: helical CT and MR imaging findings with clinical-pathologic comparison. Radiology 243 (2):422-430. https://doi.org/10.1148/radiol.2432051244

    Article  PubMed  Google Scholar 

  10. Papadatos D, Fowler KJ, Kielar AZ, Cui J, Sirlin CB (2017) Cirrhosis and LI-RADS. Abdominal Radiology 43 (1):26-40. https://doi.org/10.1007/s00261-017-1425-8

    Article  Google Scholar 

  11. Quaglia A, Tibballs J, Grasso A, Prasad N, Nozza P, Davies SE, Burroughs AK, Watkinson A, Dhillon AP (2003) Focal nodular hyperplasia-like areas in cirrhosis. Histopathology 42 (1):14-21. https://doi.org/10.1046/j.1365-2559.2003.01550.x

    Article  CAS  PubMed  Google Scholar 

  12. Nakashima O, Kurogi M, Yamaguchi R, Miyaaki H, Fujimoto M, Yano H, Kumabe T, Hayabuchi N, Hisatomi J, Sata M, Kojiro M (2004) Unique hypervascular nodules in alcoholic liver cirrhosis: identical to focal nodular hyperplasia-like nodules? Journal of Hepatology 41 (6):992-998. https://doi.org/10.1016/j.jhep.2004.08.014

    Article  CAS  PubMed  Google Scholar 

  13. Libbrecht L, Cassiman D, Verslype C, Maleux G, Van Hees D, Pirenne J, Nevens F, Roskams T (2006) Clinicopathological features of focal nodular hyperplasia-like nodules in 130 cirrhotic explant livers. Am J Gastroenterol 101 (10):2341-2346. https://doi.org/10.1111/j.1572-0241.2006.00783.x

    Article  PubMed  Google Scholar 

  14. Kim SR, Imoto S, Ikawa H, Ando K, Mita K, Shimizu K, Taniguchi M, Sasase N, Matsuoka T, Kudo M, Kawada N, Hayashi Y (2008) Focal nodular hyperplasia-like lesion with venous washout in alcoholic liver cirrhosis. Intern Med 47 (21):1899-1903. https://doi.org/10.2169/internalmedicine.47.1221

    Article  PubMed  Google Scholar 

  15. Yoneda N, Matsui O, Kitao A, Kozaka K, Kobayashi S, Sasaki M, Yoshida K, Inoue D, Minami T, Gabata T (2016) Benign Hepatocellular Nodules: Hepatobiliary Phase of Gadoxetic Acid-enhanced MR Imaging Based on Molecular Background. Radiographics : a review publication of the Radiological Society of North America, Inc 36 (7):2010–2027. https://doi.org/10.1148/rg.2016160037

  16. Kim JW, Lee CH, Kim SB, Park BN, Park YS, Lee J, Park CM (2017) Washout appearance in Gd-EOB-DTPA-enhanced MR imaging: A differentiating feature between hepatocellular carcinoma with paradoxical uptake on the hepatobiliary phase and focal nodular hyperplasia-like nodules. J Magn Reson Imaging 45 (6):1599-1608. https://doi.org/10.1002/jmri.25493

    Article  PubMed  Google Scholar 

  17. Calderaro J, Nault JC, Balabaud C, Couchy G, Saint-Paul M-C, Azoulay D, Mehdaoui D, Luciani A, Zafrani ES, Bioulac-Sage P, Zucman-Rossi J (2015) Inflammatory hepatocellular adenomas developed in the setting of chronic liver disease and cirrhosis. Modern Pathology 29 (1):43-50. https://doi.org/10.1038/modpathol.2015.119

    Article  CAS  PubMed  Google Scholar 

  18. Sasaki M, Yoneda N, Sawai Y, Imai Y, Kondo F, Fukusato T, Yoshikawa S, Kobayashi S, Sato Y, Matsui O, Nakanuma Y (2015) Clinicopathological characteristics of serum amyloid A-positive hepatocellular neoplasms/nodules arising in alcoholic cirrhosis. Histopathology 66 (6):836-845. https://doi.org/10.1111/his.12588

    Article  PubMed  Google Scholar 

  19. Shaib YH, El-Serag HB, Davila JA, Morgan R, McGlynn KA (2005) Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study. Gastroenterology 128 (3):620-626. https://doi.org/10.1053/j.gastro.2004.12.048

    Article  PubMed  Google Scholar 

  20. Razumilava N, Gores GJ (2014) Cholangiocarcinoma. The Lancet 383 (9935):2168-2179. https://doi.org/10.1016/s0140-6736(13)61903-0

    Article  Google Scholar 

  21. Huang B, Wu L, Lu X-Y, Xu F, Liu C-F, Shen W-F, Jia N-Y, Cheng H-Y, Yang Y-F, Shen F (2016) Small Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma in Cirrhotic Livers May Share Similar Enhancement Patterns at Multiphase Dynamic MR Imaging. Radiology 281 (1):150-157. https://doi.org/10.1148/radiol.2016151205

    Article  PubMed  Google Scholar 

  22. Ni T, Shang X-S, Wang W-T, Hu X-X, Zeng M-S, Rao S-X (2018) Different MR features for differentiation of intrahepatic mass-forming cholangiocarcinoma from hepatocellular carcinoma according to tumor size. The British journal of radiology 91 (1088):20180017-20180017. https://doi.org/10.1259/bjr.20180017

    Article  PubMed  PubMed Central  Google Scholar 

  23. An C, Park S, Choi YJ (2013) Diffusion-weighted MRI in intrahepatic bile duct adenoma arising from the cirrhotic liver. Korean J Radiol 14 (5):769-775. https://doi.org/10.3348/kjr.2013.14.5.769

    Article  PubMed  PubMed Central  Google Scholar 

  24. Allaire GS, Rabin L, Ishak KG, Sesterhenn IA (1988) Bile duct adenoma. A study of 152 cases. The American journal of surgical pathology 12 (9):708–715. https://doi.org/10.1097/00000478-198809000-00007

  25. Fred TB, Fatima C, Ralph HH, Neil DT (2010) WHO classification of tumours of the digestive system. International Agency for Research on Cancer, Lyon

    Google Scholar 

  26. Kim YS, Rha SE, Oh SN, Jung SE, Shin YR, Choi BG, Byun JY, Jung ES, Kim DG (2010) Imaging findings of intrahepatic bile duct adenoma (peribiliary gland hamartoma): a case report and literature review. Korean J Radiol 11 (5):560-565. https://doi.org/10.3348/kjr.2010.11.5.560

    Article  PubMed  PubMed Central  Google Scholar 

  27. Meyers AB, Towbin AJ, Geller JI, Podberesky DJ (2012) Hepatoblastoma imaging with gadoxetate disodium-enhanced MRI--typical, atypical, pre- and post-treatment evaluation. Pediatr Radiol 42 (7):859-866. https://doi.org/10.1007/s00247-012-2366-6

    Article  PubMed  Google Scholar 

  28. Rodriguez-Galindo C, Krailo M, Frazier L, Chintagumpala M, Amatruda J, Katzenstein H, Malogolowkin M, Spector L, Pashankar F, Meyers R, Tomlinson G, Committee COGRTD (2013) Children's Oncology Group's 2013 blueprint for research: rare tumors. Pediatr Blood Cancer 60 (6):1016-1021. https://doi.org/10.1002/pbc.24428

    Article  PubMed  Google Scholar 

  29. Kremer N, Walther AE, Tiao GM (2014) Management of hepatoblastoma: an update. Current opinion in pediatrics 26 (3):362-369. https://doi.org/10.1097/MOP.0000000000000081

    Article  PubMed  Google Scholar 

  30. Meyers RL (2007) Tumors of the liver in children. Surg Oncol 16 (3):195-203. https://doi.org/10.1016/j.suronc.2007.07.002

    Article  PubMed  Google Scholar 

  31. Wang TY, Han YL, Gao YJ, Xu M, Gu S, Yin MZ, Zhong YM, Hu WT, Pan C, Tang JY (2019) Retrospective Analysis of Childhood Hepatoblastoma in a Single Centre in China. Clinical Oncology 31 (7):471-478. https://doi.org/10.1016/j.clon.2019.03.044

    Article  CAS  PubMed  Google Scholar 

  32. Chung EM, Lattin GE, Jr., Cube R, Lewis RB, Marichal-Hernández C, Shawhan R, Conran RM (2011) From the archives of the AFIP: Pediatric liver masses: radiologic-pathologic correlation. Part 2. Malignant tumors. Radiographics : a review publication of the Radiological Society of North America, Inc 31 (2):483–507. https://doi.org/10.1148/rg.312105201

  33. Lin H, van den Esschert J, Liu C, van Gulik TM (2011) Systematic review of hepatocellular adenoma in China and other regions. Journal of Gastroenterology and Hepatology 26 (1):28-35. https://doi.org/10.1111/j.1440-1746.2010.06502.x

    Article  PubMed  Google Scholar 

  34. Nault JC, Paradis V, Cherqui D, Vilgrain V, Zucman-Rossi J (2017) Molecular classification of hepatocellular adenoma in clinical practice. J Hepatol 67 (5):1074-1083. https://doi.org/10.1016/j.jhep.2017.07.009

    Article  CAS  PubMed  Google Scholar 

  35. Ba-Ssalamah A, Antunes C, Feier D, Bastati N, Hodge JC, Stift J, Cipriano MA, Wrba F, Trauner M, Herold CJ, Caseiro-Alves F (2015) Morphologic and Molecular Features of Hepatocellular Adenoma with Gadoxetic Acid-enhanced MR Imaging. Radiology 277 (1):104-113. https://doi.org/10.1148/radiol.2015142366

    Article  PubMed  Google Scholar 

  36. Bioulac-Sage P, Sempoux C, Frulio N, Le Bail B, Blanc JF, Castain C, Laurent C, Trillaud H, Chiche L, Balabaud C (2019) Snapshot summary of diagnosis and management of hepatocellular adenoma subtypes. Clinics and Research in Hepatology and Gastroenterology 43 (1):12-19. https://doi.org/10.1016/j.clinre.2018.07.007

    Article  PubMed  Google Scholar 

  37. van Aalten SM, Thomeer MGJ, Terkivatan T, Dwarkasing RS, Verheij J, de Man RA, Ijzermans JNM (2011) Hepatocellular adenomas: correlation of MR imaging findings with pathologic subtype classification. Radiology 261 (1):172-181. https://doi.org/10.1148/radiol.11110023

    Article  PubMed  Google Scholar 

  38. Mao JX, Teng F, Liu C, Yuan H, Sun KY, Zou Y, Dong JY, Ji JS, Dong JF, Fu H, Ding GS, Guo WY (2019) Two case reports and literature review for hepatic epithelioid angiomyolipoma: Pitfall of misdiagnosis. World J Clin Cases 7 (8):972-983. https://doi.org/10.12998/wjcc.v7.i8.972

    Article  PubMed  PubMed Central  Google Scholar 

  39. Klompenhouwer AJ, Verver D, Janki S, Bramer WM, Doukas M, Dwarkasing RS, de Man RA, Ijzermans JNM (2017) Management of hepatic angiomyolipoma: A systematic review. Liver International 37 (9):1272-1280. https://doi.org/10.1111/liv.13381

    Article  PubMed  Google Scholar 

  40. Chia HW, Nai CC, Yi CY, Yu K, Sz SY, Ching YW, Chien AL, Yi HC, Yi YC (2016) Uncommon liver tumors: Case report and literature review. Medicine 95 (39):e4952. https://doi.org/10.1097/md.0000000000004952

    Article  Google Scholar 

  41. Danet I-M, Semelka RC, Leonardou P, Braga L, Vaidean G, Woosley JT, Kanematsu M (2003) Spectrum of MRI appearances of untreated metastases of the liver. AJR American journal of roentgenology 181 (3):809-817. https://doi.org/10.2214/ajr.181.3.1810809

    Article  PubMed  Google Scholar 

  42. Gulpinar B, Peker E, Kul M, Elhan AH, Haliloglu N (2019) Liver metastases of neuroendocrine tumors: is it possible to diagnose different histologic subtypes depending on multiphasic CT features? Abdominal Radiology 44 (6):2147-2155. https://doi.org/10.1007/s00261-019-01963-y

    Article  PubMed  Google Scholar 

  43. Park YS (2016) Differentiation of hepatocellular carcinoma from its various mimickers in liver magnetic resonance imaging: What are the tips when using hepatocyte-specific agents? World Journal of Gastroenterology 22 (1). https://doi.org/10.3748/wjg.v22.i1.284

  44. Ronot M, Cuccioli F, Dioguardi Burgio M, Vullierme M-P, Hentic O, Ruszniewski P, d’Assignies G, Vilgrain V (2017) Neuroendocrine liver metastases: Vascular patterns on triple-phase MDCT are indicative of primary tumour location. European Journal of Radiology 89:156-162. https://doi.org/10.1016/j.ejrad.2017.02.007

    Article  PubMed  Google Scholar 

  45. Sandrasegaran K, Rajesh A, Rushing DA, Rydberg J, Akisik FM, Henley JD (2005) Gastrointestinal stromal tumors: CT and MRI findings. Eur Radiol 15 (7):1407-1414. https://doi.org/10.1007/s00330-005-2647-7

    Article  PubMed  Google Scholar 

  46. Gaitanidis A, Alevizakos M, Tsaroucha A, Simopoulos C, Pitiakoudis M (2018) Incidence and predictors of synchronous liver metastases in patients with gastrointestinal stromal tumors (GISTs). Am J Surg 216 (3):492-497. https://doi.org/10.1016/j.amjsurg.2018.04.011

    Article  PubMed  Google Scholar 

Download references

Funding

This work was funded by National Natural Science Foundation of China (81971684, 81771908, and 81600508).

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Xuehua Li or Shi-Ting Feng.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interests.

Ethical approval

Formal approvals are not required for this type of study. Patients signed approvals before imaging examinations.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tang, M., Li, Y., Lin, Z. et al. Hepatic nodules with arterial phase hyperenhancement and washout on enhanced computed tomography/magnetic resonance imaging: how to avoid pitfalls. Abdom Radiol 45, 3730–3742 (2020). https://doi.org/10.1007/s00261-020-02560-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00261-020-02560-0

Keywords

Navigation